LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Genetic Structure Determined for Pathogenic Spirochete

By LabMedica International staff writers
Posted on 27 Oct 2010
Image: Colored scanning electron micrograph (SEM) of a conglomeration of Borrelia burgdorferi bacteria, cause of Lyme disease in humans (photo courtesy Juergen Berger / Science Photo Library).
Image: Colored scanning electron micrograph (SEM) of a conglomeration of Borrelia burgdorferi bacteria, cause of Lyme disease in humans (photo courtesy Juergen Berger / Science Photo Library).
The complete genetic structures of 13 strains of the bacteria that cause Lyme disease have been resolved.

Lyme disease is the most frequent tick-borne disease in North America and Europe. There are multiple variants of Borrelia burgdorferi, the causative agent, but questions remain about how their variation correlates with different clinical manifestations.

A single genome sequence is not sufficient to understand the relationship between genotypic and geographic variation and disease phenotype. In a collaborative study carried out at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School, (UMDNJ; Newark, NJ, USA), the whole genome sequence of 13 different isolates that span the range of natural variation has been determined. The strains were isolated from human and other natural sources.

New insights into Lyme disease are needed. While the bacterium that causes the disease has been known for 27 years, there still is no vaccine for humans available. The authors believe that their sequence information will help investigators design improved diagnostic tests and vaccines. Efficient tests are needed because the telltale rash on the skin does not always appear in infected patients. Cultures, which work well for many other bacteria, take too long to be of immediate use for Lyme bacteria. Serological and DNA assays have proven to be unsatisfactory. Therefore, these sequences should allow improved understanding of pathogenesis and provide a foundation for novel detection, diagnosis, and prevention strategies.

These new discoveries may accelerate research efforts to diagnose, prevent, and treat the disease, which can affect the nervous system, heart, skin, and joints. The occurrence of the disease has grown dramatically over the past ten years in the U.S. and Europe. There were nearly 30,000 new cases of Lyme disease reported in the U.S. in 2009, and cases have increased by 90% in the U.K.

Steven E. Schutzer, M.D., the senior author of the study, said, "A driving force for doing this project was the observation that certain forms of the bacteria can be more invasive than others. We wanted to find out why and how to identify this property".

The study was published in October 2010 in the Journal of Bacteriology.

Related Links:

University of Medicine and Dentistry of New Jersey




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more